Antitumor activity of L-asparaginase from Yersinia pseudotuberculosis

Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry

Volumn 3, Issue 2, 2009, Pages 198-201

  Abakumova, Olga Yu ^a   Podobed, O V ^a   Borisova, A A ^a   Sidoruk, K V ^b   Alexandrova, S S ^a   Omelyanuk, N M ^a   Pokrovskaya, M V ^a   Kondakova, L I ^c   Sokolov, N N ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b STATE RESEARCH INSTITUTE OF GENETICS AND SELECTION OF INDUSTRIAL MICROORGANISMS   (Russian Federation)

^c RESEARCH INSTITUTE OF HUMAN MORPHOLOGY   (Russian Federation)

Author keywords

Cytotoxicity; L asparaginase; Tumor cells; Yersinia pseudotuberculosis

Indexed keywords

ASPARAGINASE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST ADENOCARCINOMA; CANCER GROWTH; CANCER INHIBITION; CELL STRAIN LNCAP; CELL STRAIN MCF 7; CYTOTOXICITY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; LYMPHATIC LEUKEMIA; NEURINOMA; NONHUMAN; PECTOBACTERIUM CAROTOVORUM; PRIORITY JOURNAL; PROSTATE CARCINOMA; RAT; YERSINIA PSEUDOTUBERCULOSIS;

PECTOBACTERIUM CAROTOVORUM; RATTUS; YERSINIA PSEUDOTUBERCULOSIS;

EID: 65949118710     PISSN: 19907508     EISSN: 19907516     Source Type: Journal    
DOI: 10.1134/S1990750809020115     Document Type: Article

References (18)

1. Broome, J.D., Cancer Treat Rep., 1981, vol. 65,Suppl. 4, pp. 111-114.
2. Ollenschlager, G., Roth, E., Linkesch, W., Jansen, S., Simmel, A., and Modder, B., Eur. J. Clin. Invest., 1988, vol. 18, pp. 512-516.
3. Reinert, R.B., Oberle, L.M., Wek, S.A., Bunpo, P., Wang, X.P., Mileva, I., Goodwin, L.O., Aldrich, C.J., Durden, D.L., McNurlan, M.A., Wek, R.C., and Anthony, T.G., (2006) J. Biol. Chem., 2006, vol. 281, pp. 31222-31233.
4. Fine, B.M., Kaspers, G.J.L., Ho, M., Loonen, A.H., and Boxer, L.M., Cancer Res., 2005, vol. 65, pp. 291-299.
5. Holleman, A., denBoer, M.L., Kazemier, K.M., Janka-Schaub, G.E., and Pieters, R., Blood, 2003, vol. 15, pp. 4541-4546.
6. Aslanian, A.M., Fletcher, B.S., and Kilberg, M.S., Biochem. J., 2001, vol. 357, pp. 321-328.
7. Lorenzi, P.L., Reinhold, W.C., Rudelius, M., Gunsior, M., Shankavaran, U., Bussey, K.J., Scherf, U., Eichler, G.S., Martin, S.E., Chin, K., Gray, J.W., Kohn, E.C., Horak, I.D., Von Hoff, D.D., Raffeld, M., Goldsmith, P.K., Caplen, N.J., and Weinstein, J.N., Mol. Cancer Ther., 2006, vol. 5, pp. 2613-2623.
8. Taylor, C.W., Dorr, R.T., Fanta, P., Herch, E.M., and Salmon, S.E., Cancer Chemother. Pharmacol., 2001, vol. 47, pp. 83-88.
9. Sokolov, N.N., Zanin, V.A., and Aleksandrova, S.S., Vopr. Med. Khim., 2000, vol. 46, pp. 531-548.
10. Perel, G., Auvrignon, A., Leblax, T., Vannier, J.R., Michel, G., Nelken, G., et al., J. Clin. Oncol., 2002, vol. 20, pp. 2774-2782.
11. Kantarjan, H.M., Am. J. Med., 1994, vol. 97, pp. 176-184.
12. Fiere, D. and Danaila, C., Rev. Prat., 1996, vol. 46, pp. 55-61.
13. Meschi, F., diNatal, B., Rondanini, G.F., Uderzo, C., Jancovic, M., Masera, G., and Chiumello, G., Horm. Res., 1981, vol. 15, pp. 237-241.
14. Durden, D.L., Salazar, A.M., and Distasio, J.A., Cancer Res., 1983, vol. 43, pp. 1602-1605.
15. Cairo, M.S., Am. J. Pediatr. Hematol. Oncol., 1982, vol. 4, pp. 335-339.
16. Wade, H.E. and Philips, B.P., Anal. Biochem., 1977, vol. 44, pp. 189-199.
17. Sedmak, J.J. and Grossberry, S.E., Anal. Biochem., 1981, vol. 79, pp. 544-552.
18. Mossman, T., J. Immunol. Meth., 1983, vol. 65, pp. 55-63.